J. Trupl

Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol

V. Krčméry, F Mateička, A. Kunová et al. · Supportive Care in Cancer · 1999 · 105 citations

Radiation Oncology, Hematogenous Trichosporonosis, Cancer Patients +1

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome

V. Krčméry, E. Oravcová, S. Špánik et al. · Journal of Antimicrobial Chemotherapy · 1998 · 101 citations · Full text

Pathology, Clinical Mycology, Antimicrobial Chemotherapy +19

Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries

Kensuke Nagai, Peter C. Appelbaum, Todd A. Davies et al. · Antimicrobial Agents and Chemotherapy · 2002 · 81 citations · Full text

Penicillin G-intermediate, Antimicrobial Chemotherapy, Antibiotic Resistance +21

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs et al. · Diagnostic Microbiology and Infectious Disease · 2010 · 79 citations · Full text

Antifungal Agent, Candida Glabrata, Health Sciences +9

Carriage of Antibiotic-Resistant Streptococcus pneumoniae by Children in Eastern and Central Europe--A Multicenter Study with Use of Standardized Methods

Peter C. Appelbaum, Christina Gladkova, Waleria Hryniewicz et al. · Clinical Infectious Diseases · 1996 · 70 citations · Full text